Combigene AB Capital Reinvestment Ratio

Latest as of December 2021: 0.01x

Combigene AB capital reinvestment ratio. Combigene AB (COMBI) has a Capital Reinvestment Ratio of 0.01x as of December 2021, meaning it reinvests 0% of its operating cash flow (Skr22.11 Million) in capital expenditures (Skr147.73K). Check total reinvestment intensity of Combigene AB to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

Skr22.11 Million
SEK

Capital Expenditures

Skr147.73K
SEK

Data as of

Dec 2021
Most recent filing

Capital Reinvestment Ratio of Combigene AB (2018–2021)

Capital reinvestment ratio of Combigene AB from 2018 to 2021. This chart tracks Combigene AB's Capital Reinvestment Ratio across 2 annual periods. Also explore net asset momentum of Combigene AB to track the company's year-over-year net asset growth rate.

Combigene AB Capital Reinvestment Ratio by Year (2018–2021)

Combigene AB capital reinvestment ratio by year from 2018 to 2021. For the full cash flow conversion analysis, see Combigene AB operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2021 0.01x Skr22.11 Million Skr147.73K ▼ -99.6%
2018 1.89x Skr227.60K Skr430.20K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow